StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$44.84−1.52 (-3.28%)

Close on Nov 17, 2026Market cap $3.20BP/E –Yield –

Earnings

Pulse Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 18, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$400.00K
+365.1% on a year earlier
EPS, Q3 FY2026
-$0.32
Latest guidance
Issued
Nov 10, 2022 · 1 item

Quarterly results

Revenue and earnings per share from each of Pulse Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 18, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$400.00K+365.1%-$0.32Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$400.00K––Release
Q1 FY2026ended Mar 31, 2026May 4, 2026before the open$400.00K––Release
Q4 FY2025ended Dec 31, 2025Feb 19, 2026after the close$264.00K––Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025after the close$86.00K––Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025after the close–––Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close––-$0.25Release
Q4 FY2024ended Dec 31, 2024Mar 28, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Oct 30, 2024after the close–––Release
Q2 FY2024ended Jun 30, 2024Jul 15, 2024before the open–––Filing
Q1 FY2024ended Mar 31, 2024May 7, 2024after the close––-$0.18Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Pulse Biosciences guided for has been reported

Guidance history

Every forecast Pulse Biosciences put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 10, 2022quarterly cash burn rateQ1 FY2023$8.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Pulse Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. Results
  3. News
  4. News
  5. News
  6. Results
  7. News
  8. News
  9. Results
  10. Update
  11. Update
  12. Update
  13. Update
  14. News
  15. News

See a number that looks wrong?